Vertex Pharmaceuticals Incorporated ( VRTX) - Stock Earnings
VRTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
VRTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.2 billion USD | 3.2 billion USD |
| 2026Q1 | 1.0 billion USD | 3.0 billion USD |
| 2026Q2 | 1.1 billion USD | 3.3 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VRTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 3.6 billion USD | 9.9 billion USD |
| 2024 | -535.6 million USD | 11.0 billion USD |
| 2025 | 4.0 billion USD | 12.1 billion USD |
| 2026 Est. | — | — |
VRTX
Price: $504.50
Earnings Per Share: 17.16 USD
P/E Ratio: 28.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 142.2 millionMarket Capitalization: 127.5 billion